GFT GFT Technologies SE
GFT Technologies SE, together with its subsidiaries, provides digital transformation services. It operates in two segments in the Americas, the UK & APAC; and Continental Europe. The company offers Wynxx, a GenAI powered software delivery, Smaragd, a regulatory compliance suite, and Engenion, a project portfolio management. It also provides services including AI services, AI consulting, data services, cloud services, software engineering, infrastructure and application management, and platform modernization. GFT Technologies SE has a strategic partnership with INTEC Industrie-Technik GmbH to advance the modernization and sustainment of mission-critical systems for defense organizations through sovereign, operationally ready AI.The company serves clients in investment and retail banking, insurance, and industrial sectors. GFT Technologies SE was founded in 1987 and is headquartered in Stuttgart, Germany.…
Industry Peers
Information Technology ServicesKey Statistics
About GFT Technologies (ETR: GFT)
›
GFT Technologies (ETR: GFT) is listed on Xetra (Frankfurt), where its shares trade in EUR. It belongs to the Information Technology Services industry, part of the Technology sector, and reports about 11,887 employees.
The shares were at 24.25 EUR on 19 November 2026, up 39.4% over 52 weeks. Its 52-week range is 13.86 EUR to 29.70 EUR: the price is 18.4% below the high and 75.0% above the low.
At a market capitalisation of 619.95M EUR, it trades at 16.0 times trailing earnings and 11.6 times forward earnings. The median trailing P/E of its 20 largest Information Technology Services peers is 15.2, so GFT is valued in line with them. It pays a dividend yielding 2.06% (it pays out 33% of its earnings), against a median of 2.32% among the dividend payers in that peer group.
GFT Technologies reports return on equity of 12.5%, an operating margin of 6.3% and revenue up 11.5% year over year.
Its debt exceeds its cash by 63.86M EUR, a debt-to-equity ratio of 0.56. Its Piotroski F-score is 6 out of 9, an average reading of its financial health. 6 analysts cover the stock, with an average rating of Buy; their mean price target of 32.67 EUR is 34.7% above the current price. The next earnings report is expected on 30 March 2027.